In Vitro Activity of Farnesol Against Vaginal Lactobacillus Spp.

Fengjuan Wang,Zhaohui Liu,Dai Zhang,Xiaoxi Niu
DOI: https://doi.org/10.1016/j.ejogrb.2017.03.010
IF: 2.831
2017-01-01
European Journal of Obstetrics & Gynecology and Reproductive Biology
Abstract:Objective: Farnesol, a quorum-sensing molecule in Candida albicans, can affect the growth of certain microorganisms. The objective of this study was to evaluate the in vitro activity of farnesol against vaginal Lactobacillus spp., which play a crucial role in the maintenance of vaginal health.Methods: Growth and metabolic viability of vaginal Lactobacillus spp. incubated with different concentrations of farnesol were determined by measuring the optical density of the cultures and with the MTF assay. Morphology of the farnesol-treated cells was evaluated using a scanning electron microscope. In vitro adherence of vaginal Lactobacillus cells treated with farnesol was determined by co-incubating with vaginal epithelial cells (VECs).Results: The minimum inhibitory concentration (MIC) of farnesol for vaginal Lactobacillus spp. was 1500 mu M. No morphological changes were observed when the farnesol-treated Lactobacillus cells were compared with farnesol-free cells, and 100 mu M farnesol would reduce the adherence of vaginal Lactobacillus to VECs.Conclusion: Farnesol acted as a potential antimicrobial agent, had little impact on the growth, metabolism, and cytomorphology of the vaginal Lactobacillus spp.; however, it affected their adhering capacity to VECs. The safety of farnesol as an adjuvant for antimicrobial agents during the treatment of vaginitis needs to be studied further. (C) 2017 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?